Efficacy and Safety of Tralokinumab in US Adults with Moderate-to-Severe Atopic Dermatitis: A Post-hoc Analysis of ECZTRA3. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 7, n. 2, p. 686–695, 2023. DOI: 10.25251/skin.7.2.5. Disponível em: https://skin.dermsquared.com/skin/article/view/1871. Acesso em: 3 apr. 2025.